United States: Globalizing Your Compliance Program

I. Legal Consequences of an Inadequate Compliance Program

Multinational companies continue to face intense enforcement scrutiny related to their global compliance practices by oversight authorities worldwide. These companies rely heavily on local regulatory developments, evolving statutory structures such as the Foreign Corrupt Practices Act ("FCPA") and UK Bribery Act, and trends raised by Deferred Prosecution Agreements ("DPAs") and enforcement settlements for guidance on implementing an effective global compliance program. As recent U.S. settlements involving Orthofix, Teva Pharmaceuticals, and Olympus indicate, domestic companies that fail to adequately train, monitor, and audit compliance for ex-U.S. operations are particularly subject to intense scrutiny—each of these companies recently entered into DPAs related to FCPA allegations and settled with the U.S. Department of Justice ("DOJ") or Securities Exchange Commission ("SEC") for amounts ranging from $6 million (Orthofix) to $646 million (Olympus). In each case, the government found that compliance program implementation, oversight, and training were insufficient to prevent improper (and even overtly corrupt) conduct.1 Moreover, in the case of Teva, the DOJ found that compliance personnel were "unable or unwilling" to implement its anti-corruption programs, and for Olympus, the DOJ criticized the lack of an anti-corruption "tone at the top." Accordingly, the DOJ and SEC are requiring health care companies conducting ex-U.S. operations to do more than just "check the boxes" in establishing a compliance program—an effective compliance program requires on-the-ground and executive commitment. The most effective programs establish institutional commitment at the very outset and require ongoing monitoring and continuous updates. Companies that internally identify and self-report (when appropriate) material non-compliance with applicable legal mandates can significantly decrease the risk of regulator-imposed compliance counsel or monitorships, mitigate the threat of substantial monetary penalties, and potentially avoid other adverse consequences, such as exclusion from U.S.-based health care programs, disqualification from government contracts, and widespread reputational harm.

II. Globalizing Your Compliance Program

Organizations implementing effective global compliance programs face particular challenges in navigating disparate regulatory regimes in the numerous jurisdictions in which they may operate. Maintaining and updating regional or country-specific policies and program oversight procedures requires substantial resources and continuous updates. Faced with these challenges, some multinational companies implement uniform global compliance policies that may include requirements that are more or less restrictive than local laws. Others develop policies that identify areas of regulatory overlap and apply some consistent standards globally, and then supplement with country-specific guidance that accounts for variation in local law.2 To account for the disparate requirements in the various jurisdictions in which a company may operate, global organizations can develop analytic tools in order to identify and prioritize high-risk areas based upon locality. From there, global organizations can target these items for improvement through heightened training and monitoring programs. High-risk topics for global organizations to consider monitoring may include T&E; third-party due diligence; interactions with government entities; interactions with health care professionals; grants, donations, and sponsorships; and free product and price concessions.3

The DOJ recently offered guidance relevant to an increasingly globalized market and the unique compliance requirements associated with multinational business operations in its 2017 Evaluation of Corporate Compliance Programs guidance.4 The guidance emphasizes key elements and controls applicable to global compliance program operations, such as accessibility of policies and procedures, whether a company provides "gatekeepers" (persons with payment authority in applicable jurisdictions) clear guidance and training, and how the company uses incentives to promote ethical conduct. In addition, confidential reporting, risk assessment, auditing and control testing are emphasized as integral compliance processes. The U.S. Department of Health and Human Services, Office of the Inspector General ("OIG") has also issued compliance guidance applicable to health care and life sciences companies, which may be useful to companies in these sectors.5

All of the traditional "seven elements" of compliance programs should be designed to meet evolving global requirements, such as policies and procedures; oversight; employee and third-party screening; training and communication; auditing, monitoring and internal reporting; disciplinary actions and incentives; and investigations and remediation.6 When developing training programs, companies should tailor presentations and materials to the roles of its workforce members, and policies and training should be presented in local languages and in person, to the extent possible, with real-world examples. Regulatory oversight bodies consistently demand that compliance programs evolve to meet developing statutory structures and industry standards, identify risks through internal monitoring, and promptly implement effective corrective action plans. Specific local requirements, such as meal or gift limits, are often best built into localized standard operating procedures and should be tied to other systems (i.e., expense control systems) in order to both facilitate with compliance tracking efforts and, to the extent possible, act as a stop-gap for instances of non-compliance. For example, companies operating in South Korea and Brazil require specific focus and robust monitoring for recently enacted laws imposing spending restrictions more burdensome than under the FCPA: South Korea's "Kim Young-ran Act" sets a threshold for improper payments to public officials (whereas the FCPA prohibits certain payments regardless of amount), and includes a broader definition of public officials to encompass certain private actors, and Brazil's "Clean Companies Act" applies strict liability to interactions with public officials.

Establishing effective communications and audit processes between headquarters and regional business lines are essential for establishing accountability within global organizations. A centralized audit process is germane to an effective business model—multinational companies are advised, however, to consider implementing periodic audits as close to the ground as possible as well, to monitor training effectiveness and implementation. Single-country and even regional audits substantially increase the likelihood of identifying instances of noncompliance. Throughout the process, multinational companies should maintain strong communication channels so that if the company identifies a risk at the local level, headquarters can assess whether the problem exists elsewhere at the regional level or across multiple business lines, and can then continue to target these risks through updated training and monitoring initiatives.

 Health care companies and institutions must be proactive in their review of the specific requirements associated with cross-jurisdictional operations and deployment of institutional and local oversight mechanisms. Such efforts will help meet the evolving expectations of regulatory and enforcement agencies to operate a risk-based, global compliance program.

For more resources to help you navigate compliance obligations and risks related in an international environment, please visit our microsite: Global Health Care Compliance.

Footnotes

1 In the Teva settlement, the DOJ noted that the Company found FCPA violations through an internal audit, but failed for years to implement training around these issues. Department of Justice, Teva Pharmaceutical Industries Ltd. Agrees to Pay More than $283 Million to Resolve Foreign Corrupt Practices Act Charges, available here; in the Olympus settlement, the DOJ found that Olympus failed to appoint a compliance officer until 2009. Department of Justice, Medical Equipment Company Will Pay $646 Million for Making Illegal Payments to Doctors and Hospitals in United States and Latin America, available here.

2 In a recent survey of participants in a webinar on global compliance, including compliance officers and counsel for several multinational companies in various sectors, 64% of respondents indicated that they used global policies that set minimum standards with additional local SOPs, 4% used global policies with less strict local SOPs, and 32% used a code of conduct and all local policies/SOPs.

3 Based on a global survey of 300 senior-level executives working for multinational businesses in North America, EMEA, Asia Pacific and Latin America, in the health care, life sciences, asset management, banking, private equity and technology sectors (the "Risky Business Survey"), health care and life sciences companies identify regulation/compliance (62%), intellectual property (26%) and anti-money laundering (24%) and sanctions/export controls (24%) as high-risk topics for which they are least prepared, and therefore may require strengthened monitoring programs. More information available here.

4 Evaluation of Corporate Compliance Programs, February 2017, Department of Justice, available here

5 Measuring Compliance Program Effectiveness: A Resource Guide, March 27, 2017, Department of Health and Human Services, Office of Inspector General (OIG), pp. 24-31. While the OIG's compliance guidance includes similar themes present in the 2017 DOJ guidance, it provides more targeted, tactical content governing domestic conduct.

6 See United States Sentencing Commission, Guidelines Manual, 18 U.S.C.A. §8B2.1 (November 1, 2016).

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

Authors
 
In association with
Related Topics
 
Related Articles
 
Related Video
Up-coming Events Search
Tools
Print
Font Size:
Translation
Channels
Mondaq on Twitter
 
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
 
Email Address
Company Name
Password
Confirm Password
Position
Mondaq Topics -- Select your Interests
 Accounting
 Anti-trust
 Commercial
 Compliance
 Consumer
 Criminal
 Employment
 Energy
 Environment
 Family
 Finance
 Government
 Healthcare
 Immigration
 Insolvency
 Insurance
 International
 IP
 Law Performance
 Law Practice
 Litigation
 Media & IT
 Privacy
 Real Estate
 Strategy
 Tax
 Technology
 Transport
 Wealth Mgt
Regions
Africa
Asia
Asia Pacific
Australasia
Canada
Caribbean
Europe
European Union
Latin America
Middle East
U.K.
United States
Worldwide Updates
Registration (you must scroll down to set your data preferences)

Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice):

  • To allow you to personalize the Mondaq websites you are visiting to show content ("Content") relevant to your interests.
  • To enable features such as password reminder, news alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our content providers ("Contributors") who contribute Content for free for your use.

Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below.

Mondaq has a "free to view" business model. Our services are paid for by Contributors in exchange for Mondaq providing them with access to information about who accesses their content. Once personal data is transferred to our Contributors they become a data controller of this personal data. They use it to measure the response that their articles are receiving, as a form of market research. They may also use it to provide Mondaq users with information about their products and services.

Details of each Contributor to which your personal data will be transferred is clearly stated within the Content that you access. For full details of how this Contributor will use your personal data, you should review the Contributor’s own Privacy Notice.

Please indicate your preference below:

Yes, I am happy to support Mondaq in maintaining its free to view business model by agreeing to allow Mondaq to share my personal data with Contributors whose Content I access
No, I do not want Mondaq to share my personal data with Contributors

Also please let us know whether you are happy to receive communications promoting products and services offered by Mondaq:

Yes, I am happy to received promotional communications from Mondaq
No, please do not send me promotional communications from Mondaq
Terms & Conditions

Mondaq.com (the Website) is owned and managed by Mondaq Ltd (Mondaq). Mondaq grants you a non-exclusive, revocable licence to access the Website and associated services, such as the Mondaq News Alerts (Services), subject to and in consideration of your compliance with the following terms and conditions of use (Terms). Your use of the Website and/or Services constitutes your agreement to the Terms. Mondaq may terminate your use of the Website and Services if you are in breach of these Terms or if Mondaq decides to terminate the licence granted hereunder for any reason whatsoever.

Use of www.mondaq.com

To Use Mondaq.com you must be: eighteen (18) years old or over; legally capable of entering into binding contracts; and not in any way prohibited by the applicable law to enter into these Terms in the jurisdiction which you are currently located.

You may use the Website as an unregistered user, however, you are required to register as a user if you wish to read the full text of the Content or to receive the Services.

You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these Terms or with the prior written consent of Mondaq. You may not use electronic or other means to extract details or information from the Content. Nor shall you extract information about users or Contributors in order to offer them any services or products.

In your use of the Website and/or Services you shall: comply with all applicable laws, regulations, directives and legislations which apply to your Use of the Website and/or Services in whatever country you are physically located including without limitation any and all consumer law, export control laws and regulations; provide to us true, correct and accurate information and promptly inform us in the event that any information that you have provided to us changes or becomes inaccurate; notify Mondaq immediately of any circumstances where you have reason to believe that any Intellectual Property Rights or any other rights of any third party may have been infringed; co-operate with reasonable security or other checks or requests for information made by Mondaq from time to time; and at all times be fully liable for the breach of any of these Terms by a third party using your login details to access the Website and/or Services

however, you shall not: do anything likely to impair, interfere with or damage or cause harm or distress to any persons, or the network; do anything that will infringe any Intellectual Property Rights or other rights of Mondaq or any third party; or use the Website, Services and/or Content otherwise than in accordance with these Terms; use any trade marks or service marks of Mondaq or the Contributors, or do anything which may be seen to take unfair advantage of the reputation and goodwill of Mondaq or the Contributors, or the Website, Services and/or Content.

Mondaq reserves the right, in its sole discretion, to take any action that it deems necessary and appropriate in the event it considers that there is a breach or threatened breach of the Terms.

Mondaq’s Rights and Obligations

Unless otherwise expressly set out to the contrary, nothing in these Terms shall serve to transfer from Mondaq to you, any Intellectual Property Rights owned by and/or licensed to Mondaq and all rights, title and interest in and to such Intellectual Property Rights will remain exclusively with Mondaq and/or its licensors.

Mondaq shall use its reasonable endeavours to make the Website and Services available to you at all times, but we cannot guarantee an uninterrupted and fault free service.

Mondaq reserves the right to make changes to the services and/or the Website or part thereof, from time to time, and we may add, remove, modify and/or vary any elements of features and functionalities of the Website or the services.

Mondaq also reserves the right from time to time to monitor your Use of the Website and/or services.

Disclaimer

The Content is general information only. It is not intended to constitute legal advice or seek to be the complete and comprehensive statement of the law, nor is it intended to address your specific requirements or provide advice on which reliance should be placed. Mondaq and/or its Contributors and other suppliers make no representations about the suitability of the information contained in the Content for any purpose. All Content provided "as is" without warranty of any kind. Mondaq and/or its Contributors and other suppliers hereby exclude and disclaim all representations, warranties or guarantees with regard to the Content, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. To the maximum extent permitted by law, Mondaq expressly excludes all representations, warranties, obligations, and liabilities arising out of or in connection with all Content. In no event shall Mondaq and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use of the Content or performance of Mondaq’s Services.

General

Mondaq may alter or amend these Terms by amending them on the Website. By continuing to Use the Services and/or the Website after such amendment, you will be deemed to have accepted any amendment to these Terms.

These Terms shall be governed by and construed in accordance with the laws of England and Wales and you irrevocably submit to the exclusive jurisdiction of the courts of England and Wales to settle any dispute which may arise out of or in connection with these Terms. If you live outside the United Kingdom, English law shall apply only to the extent that English law shall not deprive you of any legal protection accorded in accordance with the law of the place where you are habitually resident ("Local Law"). In the event English law deprives you of any legal protection which is accorded to you under Local Law, then these terms shall be governed by Local Law and any dispute or claim arising out of or in connection with these Terms shall be subject to the non-exclusive jurisdiction of the courts where you are habitually resident.

You may print and keep a copy of these Terms, which form the entire agreement between you and Mondaq and supersede any other communications or advertising in respect of the Service and/or the Website.

No delay in exercising or non-exercise by you and/or Mondaq of any of its rights under or in connection with these Terms shall operate as a waiver or release of each of your or Mondaq’s right. Rather, any such waiver or release must be specifically granted in writing signed by the party granting it.

If any part of these Terms is held unenforceable, that part shall be enforced to the maximum extent permissible so as to give effect to the intent of the parties, and the Terms shall continue in full force and effect.

Mondaq shall not incur any liability to you on account of any loss or damage resulting from any delay or failure to perform all or any part of these Terms if such delay or failure is caused, in whole or in part, by events, occurrences, or causes beyond the control of Mondaq. Such events, occurrences or causes will include, without limitation, acts of God, strikes, lockouts, server and network failure, riots, acts of war, earthquakes, fire and explosions.

By clicking Register you state you have read and agree to our Terms and Conditions